Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.Financial_Report.xls
10-K - MAINBODY - Xenetic Biosciences, Inc.mainbody.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Xenetic Biosciences, Inc.R10.htm
EX-32.1 - EXHIBIT 32.1 - Xenetic Biosciences, Inc.ex32_1.htm
EX-31.2 - EXHIBIT 31.2 - Xenetic Biosciences, Inc.ex31_2.htm
EX-31.1 - EXHIBIT 31.1 - Xenetic Biosciences, Inc.ex31_1.htm
EX-10.2 - EXHIBIT 10.2 - Xenetic Biosciences, Inc.ex10_2.htm
v2.4.0.6
STOCKHOLDERS EQUITY
12 Months Ended
Aug. 31, 2012
Equity [Abstract]  
STOCKHOLDERS EQUITY

 

The Company is authorized to issue up to 90,000,000 shares of $0.001 par value common stock and 10,000,000 shares of $0.001 par value preferred stock. The Preferred Stock may be issued in one or more series, with all rights and preferences being determined by the board of directors.

 

Preferred Stock

The voting rights, rate of dividends preference in relation to other classes or series, and rights in the event of liquidation related to shares of Preferred Stock of any series are determined by the board of directors and may vary from time to time.

 

Common Stock

Holders of common stock have voting rights equal to one vote for each share of Common Stock held and are entitled to receive dividends when, and if declared by the board of directors subject to the rights of any Preferred Stock having preference as to dividends. In the event of liquidation or dissolution, subject to the rights of Preferred Stock

Holders’ are entitled to share ratably in the Corporations assets. Holders of Common Stock do not have conversion, redemption or preemptive rights.

 

On August 22, 2011, the Company issued 10,000,000 shares of its common stock to its two of its former officers and directors for cash totaling $10,000. (See Note 6)

 

On April 6, 2012, the Company sold a total of 3,500,000 shares of its common stock at a price of $0.01 per share pursuant to its initial public offering for total proceeds of $35,000.